Anika Therapeutics (ANIK) Expected to Announce Quarterly Earnings on Wednesday

Anika Therapeutics (NASDAQ:ANIK) is expected to post its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Anika Therapeutics to post earnings of ($0.01) per share and revenue of $29.00 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Anika Therapeutics Stock Performance

ANIK stock opened at $16.86 on Wednesday. The company has a market capitalization of $246.93 million, a P/E ratio of -2.54 and a beta of 0.89. The company has a fifty day moving average price of $16.87 and a 200-day moving average price of $19.98. Anika Therapeutics has a 52-week low of $15.40 and a 52-week high of $29.11.

Anika Therapeutics Company Profile

Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.